AOD-9604

LIMITED EVIDENCE

PEPTIDESfat loss

A modified fragment of human growth hormone (HGH fragment 176-191) designed to have fat-burning effects without the other effects of full HGH.

How It Works

Stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) by mimicking the fat-metabolizing portion of growth hormone without affecting blood sugar or growth.

Benefits

✓Targeted fat reduction
✓No effect on blood sugar
✓No muscle or bone growth effects
✓May support cartilage repair
✓Generally well-tolerated

Potential Side Effects

⚠Limited safety data
⚠Injection site reactions
⚠Headaches in some users
⚠Variable efficacy

FDA Status

Not FDA-approved; TGA-approved in Australia for osteoarthritis research

Clinical Evidence

Early human trials showed modest fat loss. Approved in Australia for joint research. Efficacy for fat loss is debated.

Common Dosage

300mcg daily, injected subcutaneously

⚠ Always consult with a healthcare professional before starting any new supplement or treatment.

Related Products

Tesamorelin (Egrifta)

A growth hormone-releasing hormone (GHRH) analog specifically approved for reducing visceral adipose tissue (deep belly fat).

5-Amino-1MQ

A peptide that inhibits NNMT enzyme to increase cellular metabolism.

Medical Disclaimer

The information provided on this page is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any new treatment, supplement, or making changes to your health regimen.